ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

The ACR Opposes Part B Payment Demo & Other Highlights from the AMA HOD Meeting

Gary Bryant  |  July 6, 2016

On June 15, the ACR and partnering physician specialist groups passed an American Medical Association (AMA) resolution opposing the proposed Medicare Part B drug payment demonstration during the AMA House of Delegates (HOD) meeting held June 11–15 in Chicago. Part B Payment Demo Resolution The resolution, which the ACR supported with the American Society of…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AMA House of Delegates (HOD)American Medical Association (AMA)Centers for Medicare & Medicaid Services (CMS)Medicare Part Bproposal

ACR Publishes National Research Agenda for 2016–2020

Kelly Tyrrell  |  July 6, 2016

Defining new therapeutic targets and developing new therapies are among the goals of the 2016–2020 ACR National Research Agenda. So, too, is understanding early disease states, defining triggers of autoimmunity and examining disparities in access to medication and treatment.1 Charting a Course Every five years, the Committee on Research (COR) is tasked with helping chart the…

Filed under:Legislation & AdvocacyPractice SupportProfessional Topics Tagged with:Committee on Researchtherapeutic targetsTherapies

Prepare Now to Survive MACRA

Kelly Tyrrell  |  July 5, 2016

The year 2015 brought an end to the much-maligned Sustainable Growth Rate (SGR), sometimes known as the “doc fix.” The SGR established limits on Medicare reimbursement for physicians, and each year, physicians and those lobbying on their behalf were forced to stave off drastic cuts to their payments. “The SGR was Congress’s attempt to control…

Filed under:Professional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)MACRAMedicareRISE

Periodontal Infection May Determine Best Treatment for Patients with RA

Lara C. Pullen, PhD  |  July 4, 2016

Past research has indicated that a periodontal pathogen that produces the peptidularginine deiminase (PPAD) enzyme may affect levels of anti-cyclic citrullinated peptide antibody. A new study suggests serum anti-PPAD IgG titers might be a useful biomarker for designing a personalized treatment strategy for RA…

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiologicsDisease-modifying antirheumatic drugs (DMARDs)InfectionPeriodontal diseaseRheumatoid Arthritis (RA)

The Gut Microbiome Influences Postmenopausal Bone Loss

Lara C. Pullen, PhD  |  June 27, 2016

Bone health has been successfully improved by using probiotics to influence the gut microbiome in postmenopausal women with osteoporosis. New research has gained insight into this process, uncovering that sex steroid depletion increases gut permeability resulting in inflammation and pathology in mice. Treatment with probiotics also prevents this increase in gut permeability and bone loss associated with sex steroid depletion…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bonebone lossgut microbiomeMicrobiomeOsteoporosispostmenopauseWomen

The Pay Disparity: Rheumatologist Pay Is Up, but It’s Still a Lower-Paid Specialty

Richard Quinn  |  June 17, 2016

According to a new report, rheumatology remains one of the lowest-paid specialties in medicine—despite an average pay increase of 12% over the past year. And only 44% of rheumatologists would choose the field again. Anne Bass, MD, says administrative red tape and other factors contribute to the lack of satisfaction…

Filed under:Career DevelopmentProfessional Topics Tagged with:CareerCareer satisfactionjob satisfactionrheumatologistsSalary

Christopher Ritchlin Balances Patient Care with Beekeeping Hobby

Carol Patton  |  June 13, 2016

When Christopher Ritchlin, MD, MPH, isn’t teaching students, residents and fellows at the University of Rochester Medical Center (URMC), treating patients or conducting medical research in his lab, he’s monitoring the health of another sort of patient—honeybees. For the past four years. Dr. Ritchlin, professor and chief of allergy, immunology and rheumatology at URMC, has…

Filed under:Professional TopicsProfiles Tagged with:beekeepingChristopher RitchlinhobbyProfilesrheumatologist

Rheumatology Drug Updates: Etanercept for Pediatric Plaque Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  June 13, 2016

Etanercept Submitted for Chronic, Severe Plaque Psoriasis in Children The U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application for etanercept (Enbrel) for treating pediatric patients with chronic, severe plaque psoriasis.1 The application was submitted in early January 2016 and is based on results of a one-year Phase 3 study with…

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersOther Rheumatic ConditionsPediatric Conditions Tagged with:ApprovalsBiologicsBiosimilarsclinical trialsdrugetanerceptFDAknee painOsteoarthritisPediatricplaquePsoriasisrheumatologySafety

ARHP Past Presidents Share Ties to Tucson, Arizona

Ann-Marie Lindstrom  |  June 13, 2016

The American College of Rheumatology (ACR) recognized the 50th anniversary of the Association of Rheumatology Health Professionals (ARHP) during the ACR/ARHP Annual Meeting this past November in San Francisco. The University of Arizona Arthritis Center followed up with a reception in Tucson to honor past presidents of the ARHP. The Tucson area has the highest…

Filed under:Career DevelopmentProfessional Topics Tagged with:AC&RAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)Career developmentProfilesrheumatologistTucson

University of Alabama at Birmingham’s Division of Clinical Immunology & Rheumatology Recognized for Excellence

Gretchen Henkel  |  June 13, 2016

An interdisciplinary and collaborative environment is a critical factor for the advancement of basic science and clinical research in the academic environment, says William J. Koopman, MD, former director of the University of Alabama at Birmingham’s (UAB’s) Division of Clinical Immunology and Rheumatology. And in 1977, when he was being recruited by Division Director J….

Filed under:ConditionsPediatric ConditionsProfessional TopicsProfilesResearch Rheum Tagged with:CareerexcellenceImmunologyPediatricProfileResearchrheumatologyUniversity of Alabama at Birmingham

  • « Previous Page
  • 1
  • …
  • 224
  • 225
  • 226
  • 227
  • 228
  • …
  • 336
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences